Trial Profile
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Aug 2023
Price :
$35
*
At a glance
- Drugs Verosudil (Primary) ; Timolol
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Aerie Pharmaceuticals
- 05 May 2014 New trial record